Pharmafile Logo
Pharmafocus logo
Advanced Search
Roche image

NICE U-turn on Roche leukaemia drug

December 2, 2014
Sales and Marketing Gazyvaro, MabThera, NHS, NICE, Roche, leukaemia, obinutuzumab

NICE has reversed its decision on Roche’s chronic lymphocytic leukaemia (CLL) drug Gazyvaro only two months after rejecting the drug. …

News
paolo_poletti_nucana

NuCana appoints GSK oncology head

December 2, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Paolo Paoletti, biomed, nucana

Edinburgh-based clinical stage biopharma firm NuCana BioMed has appointed Dr Paolo Paoletti to its board of directors.  Paoletti has been …

Appointment
Lilly image

AZ and Lilly Alzheimer’s drug enters trials

December 1, 2014
Research and Development, Sales and Marketing AZD3293, Alzheimer's, AstraZeneca, LY3314814, lilly

AstraZeneca and Eli Lilly have begun a Phase II/II trial for their Alzheimer’s treatment AZD3293 as the companies hope to …

News

£2 billion government plan to ‘save the NHS’

December 1, 2014
Sales and Marketing Conservatives, NHS, Osborne, UK, balls, election, spending

George Osborne in his Autumn Statement on Wednesday will announce an extra £2 billion funding for the NHS in an attempt …

News
john_blakeley_crf_health

CRF Health expands leadership team

December 1, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing crf health, enbuska, john blakeley

Clinical trials e-solutions firm CRF Health has announced two new additions to the company’s executive leadership team. John Blakeley (pictured) …

Appointment
Freeman image

George Freeman: UK pharma is vital for our landscape

December 1, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, NHS, UK, WHO, freeman, medicine, stratified

The ABPI says the UK has an opportunity to benefit from stratified medicine, and the body’s 2014 conference held in …

Feature
BI image

Boehringer’s lung cancer drug Vargatef sees EU approval

November 28, 2014
Sales and Marketing Boehringer, EU, Europe, IPF, NSCLC, lung cancer, nintedanib, ofev, vargatef

Boehringer Ingelheim’s nintedanib has received its second nod in Europe this month with the European Commission approving it for the …

News
Yitzhak Peterburg image

New Teva chairman announced

November 28, 2014
Manufacturing and Production, Sales and Marketing Phillip Frost, Teva, Yitzhak Peterburg, barer, generics, israel

Teva Pharmaceutical Industries has confirmed that Professor Yitzhak Peterburg is to serve as its new chairman from January. Peterburg who …

News
guy_heynen

Bone Therapeutics appoints Pfizer veteran

November 28, 2014

Belgium-based biotech Bone Therapeutics has appointed Dr Guy Heynen as its new chief clinical and regulatory officer. Heynen is a …

Appointment
AZ campus image

CRUK and AZ collaborate on cancer screening

November 28, 2014
Research and Development, Sales and Marketing AstraZeneca, CRUK, Cambridge, Cancer, Cancer Research UK, MRC

Cancer Research UK (CRUK) scientists are to be given access to drug discovery facilities at AstraZeneca’s Cambridge site as part …

News
GSK image

GSK Ebola vaccine ‘promising’ in early trials

November 27, 2014
Research and Development, Sales and Marketing Africa, Ebola, GSK, Takeda, Vaccine, WHO, vaccines

The first trial results for GlaxoSmithKline’s (GSK) Ebola vaccine candidate have shown that the medicine was well-tolerated and produced an …

News
Selincro image

Lundbeck’s alcohol pill given NICE approval

November 27, 2014
Sales and Marketing Lundbeck, NHS, NICE, alcohol, selincro

NICE has finally approved the use of Selincro (nalmefene) in order to help people who are dependent on alcohol cut …

News
Soliris image

NHS to get world’s most expensive drug

November 27, 2014
Sales and Marketing Alexion, NICE, aHUS, beauchamp, blood, eculizumab, soliris

UK health watchdog NICE has recommended Alexion’s Soliris for patients with the rare disease atypical haemolytic uremic syndrome (aHUS).  Soliris …

News
NHS image

NHS needs £2 billion more in funding

November 26, 2014
Medical Communications, Sales and Marketing Cameron, Hunt, Kings Fund, NHS, Osborne, king's fund, statement

Healthcare think tank the King’s Fund has called for an additional £2 billion to be injected into the NHS in …

News

UK lags behind in healthcare outcomes index

November 26, 2014
Research and Development, Sales and Marketing Japan, NHS, UK, WHO, economist, health outcomes

Whilst healthcare outcomes in the UK arguably remain among the best in the world according to recent findings by The …

News
mike_ohara

Sharp Packaging Services hires MD

November 26, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mike O’Hara, Sharp Packaging Services

Sharp Packaging Services that is a part of UDG Healthcare has announced that Mike O’Hara has joined the firm as …

Appointment
Kofi Annan speaks at the 'global crisis of depression' summit hosted in Lo

Mental and physical health should be treated equally

November 26, 2014
Medical Communications, Research and Development, Sales and Marketing Campbell, Lundbeck, depression, kofi annan, wiinberg

The need for a new approach to depression that gives it equal importance to physical health was the focus of …

News
Cell Medica image

Cell Medica gets £50 million funding

November 26, 2014
Research and Development, Sales and Marketing CMD-003, Cancer, Imperial Innovations, Invesco Perpetual, Woodford Investment Management, celk medica

Cellular immunotherapy development firm Cell Medica has confirmed the completion a £50 million investment round from key backers to progress …

News

Priority review for Novartis myeloma drug

November 26, 2014
Sales and Marketing FDA, Farydak, Novartis, daratumumab, elotuzumab, myeloma, odac

Novartis’ multiple myeloma treatment Farydak has been given an extended review by the FDA after its future seemed in jeopardy …

News
paul_workman

Institute of Cancer Research names chief executive

November 26, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ICR, Institute of Cancer Research, paul workman

Professor Paul Workman has been appointed as the chief executive of the Institute of Cancer Research. Workman who also becomes …

Appointment
The Gateway to Local Adoption Series

Latest content

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026

Rare diseases – spinal muscular atrophy

January 30, 2026

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026